Transdermal Skin Patches Market :Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Global Transdermal Skin Patches Market Based on Product ( Reservoir, Drug in Adhesive, Multilaminate, Matrix), Based on Application ( Hormone Replacement, Pain Relief, Motion Sickness, Nicotine Cessation, Neurological Disorder, Cardiovascular Disorders), Based on Distribution Channel ( Hospital Pharmacies, Retail Pharmacies, Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

The transdermal Skin Patches market was valued at USD 7244.34 million in 2020 and is anticipated to grow at USD 9572.35 million by 2027 recording a CAGR of 4.79% during the forecast period 2021-2027. Transdermal skin patches are the adhesive patches which contain medicaments, placed on the skin and delivers the specific dosage of medication into the blood stream through the skin. Global transdermal skin patches market is primarily driven by the advantages of transdermal skin patches over the oral administration of the medicaments such as ease of administration, enhanced bioavailability, onset of action and prolonged activity of the drug. In addition, adaptation of the transdermal skin patches for the pain relief and new product launches and R&D expected to boost the transdermal skin patches market over the forecast period. Moreover, transdermal skin patches help in effective administration of the drugs which have the narrow therapeutic range. In addition, elimination of the first pass metabolism effected and ease of use effect the prescription of the transdermal skin patches for the drugs having narrow therapeutic window. However, skin permeability of the range of drugs limits the growth of market. Only handful of drugs are suitable for the transdermal drug delivery. Furthermore, disadvantages such as chances of developing contact dermatitis may hamper the market growth over the forecast period. In Febrauary 2015, China National Bluestar (Group) Co, Ltd. has launched Silbone soft silicone adhesive for skin application including transdermal patches.

Transdermal Skin Patches Market

MARKET SUMMARY
-
4.79%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 4.79%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Transdermal Skin Patches Market

  • Transdermal skin patches market is segmented based on the Product,Application, distribution channel and Geogrphy
  • Transdermal Skin Patches Market gives historical, current, and future market sizes (US$ Mn) of product type and distribution channel and geographic regions.
  • This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.
  • In addition, the market report includes regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.
  • Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities).
  • Key stakeholders of the market report include suppliers, manufacturers, marketers, policy makers engaged in manufacturing and supply of Infant nutrition
Market Key Players
  • Teva Pharmaceutical Industries
  • Mylan Pharmaceuticals Inc
  • 3M Company
  • Accrux Ltd.
  • Access Pharmaceuticals Inc.
Growth

Transdermal Skin Patches Market

Global transdermal skin patches market is primarily driven by the advantages of transdermal skin patches over the oral administration of the medicaments such as ease of administration, enhanced bioavailability, onset of action and prolonged activity of the drug. In addition, adaptation of the transdermal skin patches for the pain relief and new product launches and R&D expected to boost the transdermal skin patches market over the forecast period. Moreover, transdermal skin patches help in effective administration of the drugs which have the narrow therapeutic range. In addition, elimination of the first pass metabolism effected and ease of use effect the prescription of the transdermal skin patches for the drugs having narrow therapeutic window. However, skin permeability of the range of drugs limits the growth of market. Only handful of drugs are suitable for the transdermal drug delivery. Furthermore, disadvantages such as chances of developing contact dermatitis may hamper the market growth over the forecast period.


North-America Got Significant Share

Transdermal Skin Patches Market

Geographically, global transdermal skin patches market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America market is expected to have significant growth in the market owing to the uprising of the technologies to advancement the transdermal skin patches and presence of the key market players in the region. Europe market projected to grow at notable rates owing the adoption of cutting edge technologies and state of art infrastructure and acceptance of the new technological innovations. Asia Pacific market expected to have the significant growth rate during the forecast period due to the developing healthcare infrastructure and expansion of multinational companies into the emerging Asian countries such as India and China.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015 to 2020) and forecast (2021 to 2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Transdermal Skin Patches Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

  • Teva Pharmaceutical Industries Ltd.
  • Mylan Pharmaceuticals Inc.
  • 3M Company
  • Accrux Ltd.
  • Access Pharmaceuticals Inc.

Description

The transdermal Skin Patches market was valued at USD 7244.34 million in 2020 and is anticipated to grow at USD 9572.35 million by 2027 recording a CAGR of 4.79% during the forecast period 2021-2027. Transdermal skin patches are the adhesive patches which contain medicaments, placed on the skin and delivers the specific dosage of medication into the blood stream through the skin. Global transdermal skin patches market is primarily driven by the advantages of transdermal skin patches over the oral administration of the medicaments such as ease of administration, enhanced bioavailability, onset of action and prolonged activity of the drug. In addition, adaptation of the transdermal skin patches for the pain relief and new product launches and R&D expected to boost the transdermal skin patches market over the forecast period. Moreover, transdermal skin patches help in effective administration of the drugs which have the narrow therapeutic range. In addition, elimination of the first pass metabolism effected and ease of use effect the prescription of the transdermal skin patches for the drugs having narrow therapeutic window. However, skin permeability of the range of drugs limits the growth of market. Only handful of drugs are suitable for the transdermal drug delivery. Furthermore, disadvantages such as chances of developing contact dermatitis may hamper the market growth over the forecast period. In Febrauary 2015, China National Bluestar (Group) Co, Ltd. has launched Silbone soft silicone adhesive for skin application including transdermal patches.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX